- Home
- LC vs QURE Comparison
LC vs QURE Comparison
Compare LC & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LC
- QURE
- Stock Information
- Founded
- LC 2006
- QURE 1998
- Country
- LC United States
- QURE Netherlands
- Employees
- LC N/A
- QURE N/A
- Industry
- LC Finance: Consumer Services
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- LC Finance
- QURE Health Care
- Exchange
- LC Nasdaq
- QURE Nasdaq
- Market Cap
- LC 2.0B
- QURE 1.9B
- IPO Year
- LC 2014
- QURE 2007
- Fundamental
- Price
- LC $17.74
- QURE $27.54
- Analyst Decision
- LC Buy
- QURE Strong Buy
- Analyst Count
- LC 6
- QURE 13
- Target Price
- LC $22.17
- QURE $62.33
- AVG Volume (30 Days)
- LC 1.9M
- QURE 4.7M
- Earning Date
- LC 10-22-2025
- QURE 11-10-2025
- Dividend Yield
- LC N/A
- QURE N/A
- EPS Growth
- LC 93.62
- QURE N/A
- EPS
- LC 0.89
- QURE N/A
- Revenue
- LC $1,296,102,000.00
- QURE $15,751,000.00
- Revenue This Year
- LC N/A
- QURE N/A
- Revenue Next Year
- LC $14.96
- QURE $229.18
- P/E Ratio
- LC $19.77
- QURE N/A
- Revenue Growth
- LC 16.98
- QURE N/A
- 52 Week Low
- LC $7.90
- QURE $5.86
- 52 Week High
- LC $19.88
- QURE $71.50
- Technical
- Relative Strength Index (RSI)
- LC 55.42
- QURE 33.96
- Support Level
- LC $15.56
- QURE $26.76
- Resistance Level
- LC $16.85
- QURE $29.99
- Average True Range (ATR)
- LC 0.77
- QURE 2.67
- MACD
- LC -0.05
- QURE -0.10
- Stochastic Oscillator
- LC 58.71
- QURE 37.32
About LC LendingClub Corporation
LendingClub Corp is a company engaged in operating an online lending marketplace platform that connects borrowers and investors for the provision of the loan facility. It offers investors access to an asset class that has generally been closed to many investors and only available on a limited basis to institutional investors. The company through the platform offers loan products such as personal, education and patient finance, small business, and auto to interested investors. It generates a majority of the revenue from the transaction fees received from the platform's role in accepting and decisioning applications on behalf of the bank partners to enable loan originations.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.